Skip to main content
SLAS2024 Main banner
Sartorius Ad
Back

Nathan P. Coussens, PhD

Frederick National Laboratory for Cancer Research, Maryland, United States

Nathan P. Coussens, Ph.D., is the director of the Molecular Pharmacology Laboratories at the Frederick National Laboratory for Cancer Research (FNLCR), where he leads four teams focused on the preclinical development of cancer therapeutics. Previously he was a senior research scientist at the National Center for Advancing Translational Sciences (NCATS), where he advanced a diverse portfolio of projects. At NCATS he developed biologically and pharmacologically relevant biochemical and cell-based assays and applied advanced measurement technologies to identify and characterize small molecule modulators from high-throughput screens. Dr. Coussens is a member of the FNLCR Scientific Standards Hub, which strives to increase the reproducibility of biomedical data within the scientific community. He is a member of the SLAS Technology editorial board as well as an associate editor and former editor-in-chief of the National Institutes of Health’s Assay Guidance Manual, a growing online eBook of best practices for preclinical assay development and implementation that has become the go-to resource for translational scientists in industry, academia, and research laboratories worldwide.

Disclosure information not submitted.

Presentation(s):